An International survey on living kidney donation and transplant practices during the COVID‐19 pandemic
Autor: | Alexandre Loupy, Paolo R. Salvalaggio, Lúcio Roberto Requião Moura, Krista L. Lentine, David A. Axelrod, Yasar Caliskan, Tainá Veras de Sandes-Freitas, Ngan N. Lam, Luke S. Vest, Rafael A Maldonado, Gustavo Ferreira, Mark A. Schnitzler |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Telemedicine Asia Internationality Tissue and Organ Procurement Coronavirus disease 2019 (COVID-19) Telehealth 030230 surgery 03 medical and health sciences Patient safety Middle East 0302 clinical medicine Practices COVID‐19 Surveys and Questionnaires Pandemic medicine Living Donors Humans Mass Screening Evaluation Personal protective equipment Personal Protective Equipment Mass screening Kidney transplantation Transplantation business.industry SARS-CoV-2 Living Kidney Donation COVID-19 Original Articles medicine.disease Kidney Transplantation Europe Latin America Infectious Diseases Family medicine COVID-19 Nucleic Acid Testing North America Tissue and Organ Harvesting 030211 gastroenterology & hepatology Original Article Patient Safety business Delivery of Health Care |
Zdroj: | Transplant Infectious Disease |
ISSN: | 1399-3062 1398-2273 |
DOI: | 10.1111/tid.13526 |
Popis: | The scope of the impact of the Coronavirus disease 19 (COVID‐19) pandemic on living donor kidney transplantation (LDKT) practices across the world is not well defined. We received survey responses from 204 transplant centers internationally from May to June 2020 regarding the impact of the COVID‐19 pandemic on LDKT practices. Respondents represented 16 countries on 5 continents. Overall, 75% of responding centers reported that LDKT surgery was on hold (from 67% of North American centers to 91% of European centers). The majority (59%) of centers reported that new donor evaluations were stopped (from 46% of North American centers to 86% of European centers), with additional 23% of centers reporting important decrease in evaluations. Only 10% of centers reported slight variations on their evaluations. For the centers that continued donor evaluations, 40% performed in‐person visits, 68% by video, and 42% by telephone. Center concerns for donor (82%) and recipient (76%) safety were the leading barriers to LDKT during the pandemic, followed by patients concerns (48%), and government restrictions (46%). European centers reported more barriers related to staff limitations while North and Latin American centers were more concerned with testing capacity and insufficient resources including protective equipment. As LDKT resumes, 96% of the programs intend to screen donor and recipient pairs for coronavirus infection, most of them with polymerase chain reaction testing of nasopharyngeal swab samples. The COVID‐19 pandemic has had broad impact on all aspects of LDKT practice. Ongoing research and consensus‐building are needed to guide safe reopening of LDKT programs. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |